An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Teladoc Health, Inc. (NYSE:TDOC) issues inducement awards to three new employees, granting options to purchase 106,255 shares of common stock and awards of restricted stock units covering 86,154 shares. The options and stock units vest based on continued service to the company, approved by the Compensation Committee of the Board of Directors under the 2023 Employment Inducement Incentive Award Plan.
Positive
None.
Negative
None.
PURCHASE, NY, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to three new employees.
Effective December 1, 2023 and December 5, 2023, in connection with commencing employment, three new non-executive employees of Teladoc Health were granted options to purchase an aggregate of 106,255 shares of Teladoc Health’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price per share of $18.97 and $18.51, respectively, and awards of restricted stock units covering an aggregate of 86,154 shares of Common Stock. The stock options vest, based on continued service to Teladoc Health, as to twenty-five percent of the underlying shares on December 1, 2024, with the remainder of the options vesting monthly over three years thereafter. The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on December 1, 2024, with the remainder vesting quarterly over two years thereafter. The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
Teladoc Health, Inc. announced the issuance of inducement awards to three new employees.
How many shares were granted to the new employees?
The new employees were granted options to purchase an aggregate of 106,255 shares of Teladoc Health’s common stock and awards of restricted stock units covering an aggregate of 86,154 shares of Common Stock.
How do the stock options vest?
The stock options vest, based on continued service to Teladoc Health, as to twenty-five percent of the underlying shares on December 1, 2024, with the remainder vesting monthly over three years thereafter.
What is the purpose of the awards?
The awards were granted as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.
Under which plan were the awards granted?
The awards were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan.
Who approved the awards?
The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health.
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.
